Considerations about the efficacy of psychopharmacological drugs;Überlegungen zur Wirksamkeit von Psychopharmaka

Nervenarzt

Volumn 82, Issue 11, 2011, Pages 1425-1430

  Leucht, S ^a   Heres, S ^a   Davis, J M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Efficacy; Meta analysis; Psychiatry; Psychopharmacology; Systematic review

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; DRUG EFFICACY; DRUG INDUSTRY; EFFECT SIZE; EVIDENCE BASED MEDICINE; HUMAN; PSYCHOPHARMACOTHERAPY;

EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 80755159568     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-011-3349-9     Document Type: Article

References (37)

1. Baigent C, Blackwell L, Collins R et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849-1860
2. Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267-1278
3. Barbui C, Furukawa TA, Cipriani A (2008) Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ 178:296-305 (Pubitemid 351212875)
4. Barbui C, Guaiana G, Hotopf M (2004) Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis 127. Pharmacopsychiatry 37:93-97 (Pubitemid 38680328)
5. Bech P, Cialdella P, Haugh MC et al (2000) Meta-analysis of randomised controlled trials of fluoxetine vs placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry 176:421-428 (Pubitemid 30249617)
6. Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362:1527-1535
7. Buscemi N, Vandermeer B, Friesen C et al (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22:1335-1350 (Pubitemid 47247294)
8. Cole JO (1964) Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry 10:246-261
9. Davis JM, Schaffer CB, Killian GA et al (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6:70-87 (Pubitemid 10066395)
10. Davis JM, Wang Z, Janicak PG (1993) A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacol Bull 29:175-181 (Pubitemid 23311521)
11. Fournier JC, DeRubeis RJ, Hollon SD et al (2010) Antidepressant drug effects and depression severity. A patient-level meta-analysis. JAMA 303:47-53
12. Geddes JR, Carney SM, Davies C et al (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653-661 (Pubitemid 36246547)
13. Hansen R, Gaynes B, Thieda P et al (2008) Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatr Serv 59:1121-1130
14. Holbrook AM, Crowther R, Lotter A et al (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162:225-233 (Pubitemid 30073249)
15. Janicak PG, Davis JM, Preskorn SH, Ayd FJ (1993) Principles and practice of psychopharmacology. Williams and Wilkins, Baltimore
16. Kirsch I, Deacon BJ, Huedo-Medina TB et al (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5:e45
17. Komossa K, Depping AM, Heres S et al (2009) Maintenance treatment with antipsychotic drugs for schizophrenia (protocol). Cochrane Database Syst Rev (4). Art. No.: CD008016. DOI 10.1002/14651858.CD008016
18. Law M, Morris JK, Jordan R, Wald N (2005) Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants. Circulation 112:2301-2306 (Pubitemid 41464573)
19. Lee VC, Rhew DC, Dylan M et al (2004) Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction. Ann Intern Med 141:693-704 (Pubitemid 39434842)
20. Leucht S, Hierl S, Dold M et al (2011) Putting the efficacy of psychiatric and general medicine medication in perspective: a review of meta-analyses. Br J Psychiatry (in pess)
21. Leucht S, Kane JM, Kissling W et al (2005) What does the PANSS mean? Schizophr Res 79:231-238 (Pubitemid 41457263)
22. Leucht S, Kissling W, Davis JM (2009) Second-generation antipsychotic drugs for schizophrenia: can we resolve the conflict? Psychol Med 39:1591-1602
23. Lieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223 (Pubitemid 41345943)
24. Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev:CD003225
25. Lopez AD, Mathers CD, Ezzati M et al (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757 (Pubitemid 43767064)
26. McCrory DC, Gray RN (2003) Oral sumatriptan for acute migraine. Cochrane Database Syst Rev:CD002915
27. Moncrieff J (1995) Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br J Psychiatry 167:569-573
28. Nelson HS, Weiss ST, Bleecker ER et al (2006) The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129:15-26 (Pubitemid 43265239)
29. Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572 (Pubitemid 351831357)
30. Rice GP, Incorvaia B, Munari L et al (2001) Interferon in relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev:CD002002
31. Sinyor M, Schaffer A, Levitt A (2010) The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry 55:126-135
32. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M (2008) Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev:CD001765
33. Storosum JG, Elferink AJ, van Zwieten BJ et al (2001) Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study. Eur Neuropsychopharmacol 11:173-180 (Pubitemid 32335560)
34. Medical Research Council (1948) Streptomycin in tuberculosis trials committee: streptomycin treatment of pulmonary tuberculosis. Br Med J 2:769-782
35. Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
36. Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 48:730-738
37. Turner EH, Matthews AM, Linardatos E et al (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358:252-260